Interventional procedures versus medical therapy alone: outcome of cardiac patient management - a systematic review

Ahmed Abuosa1, Ayman Elshiekh1, Abdulhalim J Kinsara2

  • 1Ministry of National Guard Health Affair, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.

Minerva Cardioangiologica
|February 22, 2020
PubMed

Insights

Interventions benefit ST-segment-elevation myocardial infarction (STEMI) patients, while medication improves survival for heart failure and hypertension. Not all cardiac interventions offer survival advantages.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Evidence-Based Practice

Background:

  • Cardiac patients require management via medication or intervention.
  • The comparative survival benefits of these approaches are crucial for clinical decision-making.

Purpose of the Study:

  • To review current evidence on the survival benefits of medical management versus interventional procedures in various cardiac conditions.
  • To identify which cardiac patient populations benefit most from specific treatment strategies.

Main Methods:

  • Systematic review of recent clinical trials and guidelines.
  • Analysis of survival data for patients with ST-segment-elevation myocardial infarction (STEMI), chronic stable coronary artery disease, heart failure, valve disease, atrial fibrillation, hypertension, and dyslipidemia.

Main Results:

  • Primary cardiac intervention improves survival in STEMI patients.
  • Medical therapy demonstrates survival benefits in heart failure, hypertension, and dyslipidemia (when target goals are met).
  • Interventions showed no mortality benefit in chronic stable coronary artery disease or atrial fibrillation (CABANA trial). Mild/moderate valve disease does not necessitate intervention.

Conclusions:

  • Medical therapy offers significant survival benefits for numerous cardiac conditions.
  • Interventional procedures are not universally superior and should be selectively applied based on evidence.
  • Tailoring treatment strategies to specific cardiac diagnoses is essential for maximizing patient survival.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
249
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
189
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
190
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
198